Daraxonrasib doubles pancreatic cancer survival in trials, cuts mortality 60%
NewsBytes | April 20, 2026 5:40 PM CST
Daraxonrasib offers options for nonresponders
Daraxonrasib inhibits RAS proteins, giving new options to those who have not responded to other treatments.
Sen. Ben Sasse, who received the drug, saw his tumor markers drop significantly, another sign this could be a game-changer.
Revolution Medicines is also testing daraxonrasib in lung cancer and working on even better versions, so there is real hope for more progress soon.
READ NEXT
-
Gold Price Today: Gold Slips Again, 24K Rate Falls to ₹1,54,890 in Delhi; Silver Also Declines
-
UP Board 10th-12th Result 2026: At what time will the UP Board results be released? Check on upmsp.edu.in and DigiLocker..
-
To pass the UP Board Class 10 examination, 33% marks are mandatory; students who fail will have to appear for a compartment examination..
-
UPMSP UP Board 10th & 12th Results 2026: UP Board Class 10 and 12 Results Today..
-
UP Board Result 2026: How to Get UP Board Class 10 and 12 Results on WhatsApp? Download Marksheet..
